SynthesisFrontiers in oncology2026
Parental and childhood exposures and the risk of retinoblastoma, hepatoblastoma, and germ cell, bone, and soft tissue tumors in children: a systematic review and meta-analysis.
Synthesis in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Retinoblastoma, hepatoblastoma, germ cell tumors, bone tumors, and soft tissue tumors are rare types of childhood cancer. Identifying modifiable risk factors is essential to inform primary prevention. This review aimed to systematically examine literature and synthesize risk factors for childhood rare cancers. Methods: PubMed, Web of Science, and Embase databases were searched using lists of keywords and MeSH terms related to parental and childhood exposures. Studies were included if they were case-control or cohort studies of children under the age of 20 years at diagnosis and reported relative risks (RRs) with 95% confidence intervals (95% CIs). Pooled effect sizes (ES) and CIs for risk factors were estimated using random-effects models. Results: A total of 75 eligible articles from Asia, Europe, Latin America, North America, and Oceania reported cases of rare childhood cancers diagnosed between 1953 and 2021. Birth weight <2,500 g was associated with hepatoblastoma (ES 3.33, 95% CI 1.30-8.54) with considerable heterogeneity across studies. A borderline association was observed for retinoblastoma (ES 1.27, 95% CI 0.99-1.63), while the estimate for germ cell tumors was elevated, albeit with a wide CI (ES 1.20, 95% CI 0.80-1.80). No association was observed for bone tumors or soft tissue tumors. Small for gestation age was associated with hepatoblastoma (ES 1.76, 95% CI 1.28-2.43). Birth weight >4,000 g was not associated with any of the studied cancer types. Assisted reproductive technology (ES 2.82, 95% CI 1.82-4.39), Caesarean section (ES 1.47, 95% CI 1.20-1.79), and parental age >35 years (mothers ES 1.97, 95% CI 1.45-2.68; fathers ES 1.33, 95% CI 0.99-1.79) were observed to be associated with hepatoblastoma. Paternal smoking during preconception/pregnancy was associated with an increased risk of hepatoblastoma (ES = 1.58, 95% CI 1.18-2.12). Paternal occupational exposure to pesticides during preconception/pregnancy was associated with an increased risk of retinoblastoma (ES = 1.55, 95% CI 1.09-2.21). For some other exposures, we found several raised ES but with very wide CIs. Discussion: We identified only a few modifiable risk factors for certain childhood cancers, notably paternal smoking for hepatoblastoma and paternal occupational exposure to pesticides for retinoblastoma. Larger studies for rare childhood cancers are needed, with international collaboration to increase sample sizes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.